Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04QZD
|
||||
| Former ID |
DNC000619
|
||||
| Drug Name |
Eslicarbazepine
|
||||
| Synonyms |
Aptiom; BIA 2-093; ESL; Exalief; SEP-0002093; SEP-2093; Stedesa; Zebinix
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Neurology Agents
|
||||
| Formula |
C15H14N2O2
|
||||
| InChI |
InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1
|
||||
| InChIKey |
BMPDWHIDQYTSHX-AWEZNQCLSA-N
|
||||
| CAS Number |
CAS 236395-14-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
14847818, 24169052, 45628457, 61013447, 74832373, 96025895, 103293530, 118310966, 126665681, 127537462, 135253067, 143479487, 162188093, 163124654, 163696949, 164230651, 164763126, 172860101, 175266523, 178103922, 198977350, 204360581, 219401211, 223533430, 223653619, 224675811, 226744763, 249855365, 250218635, 252077440, 252429028
|
||||
| SuperDrug ATC ID |
N03AF04
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Blocker | [536934] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
| Ref 532651 | 2013 FDA drug approvals. Nat Rev Drug Discov. 2014 Feb;13(2):85-9. | ||||
| Ref 542371 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7350). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.